Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 286–300 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3173 CYCS Gene Thrombocytopenia Type 4 Genetic Test This test evaluates the CYCS gene for pathogenic variants associated with congenital thrombocytopenia type 4.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYCS gene sequence", "Pathogenic variants", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counseling session to document three-generation family pedigree"] Indications ["Suspected congenital thrombocytopenia type 4", "Family history of CYCS-related thrombocytopenia", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81499-9 ICD-10: D69.4 Clinical summary This test evaluates the CYCS gene for pathogenic variants associated with congenital thrombocytopenia type 4.
TEST-6191 CYP11B2 Gene Sequencing for Congenital Hypoaldosteronism (CMO II Deficiency) Test This test identifies pathogenic variants in the CYP11B2 gene associated with congenital hypoaldosteronism (CMO II deficiency).	Whole Blood (EDTA) or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CYP11B2 gene"] Parameters [] Preparation ["Genetic counseling session required", "Clinical history documentation required", "Pedigree chart documentation required"] Indications ["Suspected congenital hypoaldosteronism", "Family history of CMO II deficiency", "Screening of affected family members"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: E27.4 Clinical summary This test identifies pathogenic variants in the CYP11B2 gene associated with congenital hypoaldosteronism (CMO II deficiency).
TEST-6304 CYP1A2 Gene Cytochrome P450 Deficiency Genetic Test This genetic test evaluates the CYP1A2 gene for variants that affect drug metabolism capacity.	Whole Blood (peripheral) or Dry Blood Spot on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP1A2 gene variants", "Metabolic capacity for specific drugs"] Parameters [] Preparation ["Pre-test genetic counselling session required", "Pedigree chart documentation required"] Indications ["Personalised medication dosing", "Reducing adverse drug reactions", "Pharmacogenomic risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 69900-6 ICD-10: Z13.71, Z13.79, Z15.89 Clinical summary This genetic test evaluates the CYP1A2 gene for variants that affect drug metabolism capacity.
TEST-6135 CYP7B1 Gene Bile Acid Synthesis Defect Type 3 Congenital Genetic Test This test identifies genetic variants in the CYP7B1 gene associated with congenital bile acid synthesis defect type 3.	Whole Blood (2–3 mL EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP7B1 gene sequence", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected congenital bile acid synthesis defect type 3", "Family history of the disorder", "Evaluation of unexplained liver disease or neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 92791-8 ICD-10: E78.70 Clinical summary This test identifies genetic variants in the CYP7B1 gene associated with congenital bile acid synthesis defect type 3.
TEST-5690 CYP7B1 Gene SPG5A Genetic Test This test identifies pathogenic variants in the CYP7B1 gene, which are responsible for hereditary spastic paraplegia type 5A (SPG5A).	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP7B1 gene sequence", "Pathogenic variants (point mutations, insertions/deletions, splice-site variants)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": ">99.9%"}, {"name": "Analytical Specificity", "reference_range": ">99%"}] Preparation ["No special diet or medication stop is needed"] Indications ["Unexplained progressive lower-limb spasticity", "Gait disturbance", "Positive family history of autosomal recessive spastic paraplegia", "Differentiation from other spastic paraplegias", "Reproductive risk counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81205-3 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the CYP7B1 gene, which are responsible for hereditary spastic paraplegia type 5A (SPG5A).
TEST-6208 D2HGDH Gene Next‑Generation Sequencing (NGS) Test for D‑2‑Hydroxyglutaric Aciduria Type 1 This test evaluates the D2HGDH gene for pathogenic variants associated with D‑2‑hydroxyglutaric aciduria type 1.	Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["D2HGDH gene sequence", "Pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "Avoid sample collection during acute hemolytic crisis or within 4 weeks of a blood transfusion"] Indications ["Suspected D‑2‑hydroxyglutaric aciduria type 1", "Family history of the disorder", "Neurological symptoms suggestive of a neurometabolic disorder"] Measurement technique Confirm with laboratory Codes LOINC: 78014-4 ICD-10: E72.8 Clinical summary This test evaluates the D2HGDH gene for pathogenic variants associated with D‑2‑hydroxyglutaric aciduria type 1.
TEST-4209 DBH Gene (Dopamine Beta-Hydroxylase) Deficiency Genetic Test This genetic test evaluates the dopamine beta-hydroxylase (DBH) gene for variants associated with DBH deficiency, a rare disorder affecting autonomic function.	Peripheral Whole Blood (EDTA) or FTA Card	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DBH gene", "Copy-number alterations in the DBH gene", "Deep intronic mutations in the DBH gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without physician instruction"] Indications ["Individuals with unexplained fainting episodes", "Individuals with low blood pressure upon standing", "Individuals with exercise intolerance", "Individuals with a family history of sudden cardiac events despite normal cardiac workup"] Measurement technique Confirm with laboratory Codes LOINC: 94086-1 ICD-10: E70.8 Clinical summary This genetic test evaluates the dopamine beta-hydroxylase (DBH) gene for variants associated with DBH deficiency, a rare disorder affecting autonomic function.
TEST-3732 DCPS Gene Al-Raqad Syndrome Genetic Test This test provides a definitive molecular diagnosis for Al-Raqad syndrome by sequencing the entire DCPS gene.	Peripheral Whole Blood (EDTA) • Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DCPS gene sequence", "Copy Number Variants (CNV) in DCPS gene"] Parameters [] Preparation ["Provide complete clinical history", "Provide family pedigree"] Indications ["Suspected Al-Raqad syndrome", "Family history of Al-Raqad syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81329-1 ICD-10: Q87.8 Clinical summary This test provides a definitive molecular diagnosis for Al-Raqad syndrome by sequencing the entire DCPS gene.
TEST-5009 DDX3X Gene X‑Linked Intellectual Disability Type 102 Genetic Test This genetic test analyzes the DDX3X gene to detect pathogenic variants associated with X-linked intellectual disability type 102.	Whole blood (EDTA), buccal swab, or extracted DNA	3–4 weeks (STAT 7 days available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DDX3X gene", "Copy number variants (CNVs) in the DDX3X gene"] Parameters [] Preparation [] Indications ["Males with unexplained global developmental delay, moderate-to-severe intellectual disability, hypotonia, and/or movement disorders", "Females with mild intellectual disability or skewed X-inactivation"] Measurement technique Confirm with laboratory Codes LOINC: 94222-4 ICD-10: F78.9 Clinical summary This genetic test analyzes the DDX3X gene to detect pathogenic variants associated with X-linked intellectual disability type 102.
TEST-6007 DECR1 Gene Analysis (2,4-Dienoyl-CoA Reductase 1) Genetic Test This test detects pathogenic variants in the DECR1 gene associated with mitochondrial fatty acid oxidation disorders.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DECR1 gene", "Single-nucleotide variants", "Small indels"] Parameters [] Preparation ["Pre-test genetic counselling session is mandatory"] Indications ["Unexplained hypoglycaemia", "Skeletal myopathy", "Dilated cardiomyopathy", "Family history of fatty acid oxidation disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E71.318, Z15.89, E88.89 Clinical summary This test detects pathogenic variants in the DECR1 gene associated with mitochondrial fatty acid oxidation disorders.
TEST-968 Deoxycorticosterone (DOC) Test This diagnostic test evaluates adrenal gland function by quantifying deoxycorticosterone (DOC) levels in serum.	Serum	2–3 weeks (batch processing by 7th of month)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Deoxycorticosterone (DOC) levels", "Adrenal gland function"] Parameters [{"name": "Deoxycorticosterone (DOC)", "reference_range": null}] Preparation ["No special fasting required, confirm with ordering doctor", "Avoid biotin supplements for 72 hours before draw", "Continue prescribed medications unless instructed otherwise by clinician"] Indications ["Diagnosis of congenital adrenal hyperplasia", "Diagnosis of adrenal adenomas", "Diagnosis of hyperaldosteronism"] Measurement technique Confirm with laboratory Codes LOINC: 2694-1 ICD-10: E26.9, E25.9 Clinical summary This diagnostic test evaluates adrenal gland function by quantifying deoxycorticosterone (DOC) levels in serum.
TEST-1009 Deoxypyridinoline (DPD) Crosslinks Urine Test This test measures urinary deoxypyridinoline (DPD), a specific marker of bone resorption, normalized to creatinine.	Urine (random specimen, 10–20 mL)	2–3 Weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Deoxypyridinoline (DPD)", "Bone Resorption"] Parameters [{"name": "Deoxypyridinoline (DPD) / Creatinine Ratio", "reference_range": null}] Preparation ["Provide a random urine specimen (minimum 10 mL) in a sterile container", "Avoid calcium supplements or high-dose biotin 24 hours prior"] Indications ["Diagnosis of osteoporosis", "Monitoring anti-resorptive therapy efficacy", "Assessment of metabolic bone disorders"] Measurement technique Confirm with laboratory Codes LOINC: 14678-2 ICD-10: M81.0, Z13.820 Clinical summary This test measures urinary deoxypyridinoline (DPD), a specific marker of bone resorption, normalized to creatinine.
TEST-4342 DEPDC5 Genetic Test for Familial Focal Epilepsy with Variable Foci This test identifies pathogenic variants in the DEPDC5 gene associated with familial focal epilepsy with variable foci.	Peripheral Blood, Extracted DNA, or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DEPDC5 gene sequence", "Copy Number Variations (CNV) in DEPDC5 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of familial focal epilepsy with variable foci", "Family risk assessment", "Guiding antiepileptic therapy"] Measurement technique Confirm with laboratory Codes LOINC: 96609-6 ICD-10: G40.0 Clinical summary This test identifies pathogenic variants in the DEPDC5 gene associated with familial focal epilepsy with variable foci.
TEST-980 Des-Gamma-Carboxy Prothrombin (DCP)/PIVKA-II Serum Test This diagnostic test evaluates levels of abnormal des-gamma-carboxy prothrombin, a protein produced by hepatocellular carcinoma cells.	Serum	Same-day report if sample received by 9 AM	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Des-Gamma-Carboxy Prothrombin (DCP)", "PIVKA-II (Protein Induced by Vitamin K Absence or Antagonist-II)"] Parameters [{"name": "Des-Gamma-Carboxy Prothrombin (DCP)", "reference_range": null}] Preparation ["No special fasting required", "Inform phlebotomist of all current medications", "Vitamin K supplements should be withheld for 24 hours prior to collection if medically safe"] Indications ["Detection and monitoring of hepatocellular carcinoma (HCC)", "Complementary testing when AFP is inconclusive", "Screening in high-risk patients (e.g., cirrhosis, chronic hepatitis B/C)"] Measurement technique Confirm with laboratory Codes LOINC: 30501-9 ICD-10: C22.0, Z12.09 Clinical summary This diagnostic test evaluates levels of abnormal des-gamma-carboxy prothrombin, a protein produced by hepatocellular carcinoma cells.
TEST-972 Desipramine Therapeutic Drug Monitoring Test This test measures the concentration of desipramine in the patient's serum to guide dosage adjustments.	Serum (Red Top, No Additive)	2–3 weeks (scheduled batch processing)	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Desipramine Concentration"] Parameters [{"name": "Desipramine", "reference_range": null}] Preparation ["Fasting stable-state specimen collected >12 hours post-dose", "Accompany with fully completed Test Send Out Consent Form (Form 35)"] Indications ["Monitoring therapeutic levels", "Assessing adherence", "Guiding dose adjustments", "Investigating toxicity"] Measurement technique Confirm with laboratory Codes LOINC: 3538-0 ICD-10: Z51.81 Clinical summary This test measures the concentration of desipramine in the patient's serum to guide dosage adjustments.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories